China Shineway Pharmaceutical Group Limited revenue reports
China Shineway Pharmaceutical Group Limited financial reports, China Shineway Pharmaceutical Group Limited annual revenue in 2024. When does China Shineway Pharmaceutical Group Limited report revenue?
China Shineway Pharmaceutical Group Limited total revenue, net income and dynamics of changes in Euro today
The dynamics of China Shineway Pharmaceutical Group Limited net revenue has changed by 0 € over the last period. Net income China Shineway Pharmaceutical Group Limited - 20 656 000 €. Information about net income is used from open sources. Net income, revenue and dynamics - the main financial indicators of China Shineway Pharmaceutical Group Limited. Graph of the financial report of China Shineway Pharmaceutical Group Limited. The financial report schedule from 30/09/2018 to 31/12/2020 is available online. A graph of the value of all China Shineway Pharmaceutical Group Limited assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
683 129 352.76 €
+15.85 % ↑
19 256 039.60 €
-83.399 % ↓
30/09/2020
683 129 352.76 €
+15.85 % ↑
19 256 039.60 €
-83.399 % ↓
30/06/2020
554 726 079.60 €
-13.0213 % ↓
118 262 529.61 €
-11.797 % ↓
31/03/2020
554 726 079.60 €
-13.0213 % ↓
118 262 529.61 €
-11.797 % ↓
30/06/2019
637 772 411.50 €
-
134 080 057.30 €
-
31/03/2019
637 772 411.50 €
-
134 080 057.30 €
-
31/12/2018
589 652 355.34 €
-
115 992 561.74 €
-
30/09/2018
589 652 355.34 €
-
115 992 561.74 €
-
Show:
to
China Shineway Pharmaceutical Group Limited financial report charts
The latest dates of China Shineway Pharmaceutical Group Limited financial statements available online: 30/09/2018, 30/09/2020, 31/12/2020. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of China Shineway Pharmaceutical Group Limited for today is 31/12/2020. Gross profit China Shineway Pharmaceutical Group Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit China Shineway Pharmaceutical Group Limited is 555 740 500 €
China Shineway Pharmaceutical Group Limited quarterly report dates
Cost of revenue China Shineway Pharmaceutical Group Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue China Shineway Pharmaceutical Group Limited is 177 054 000 € Total revenue China Shineway Pharmaceutical Group Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue China Shineway Pharmaceutical Group Limited is 732 794 500 € Operating income China Shineway Pharmaceutical Group Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income China Shineway Pharmaceutical Group Limited is 130 722 000 €
Net income China Shineway Pharmaceutical Group Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income China Shineway Pharmaceutical Group Limited is 20 656 000 € Current assets China Shineway Pharmaceutical Group Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets China Shineway Pharmaceutical Group Limited is 5 519 037 000 € Total assets China Shineway Pharmaceutical Group Limited refers to the total amount of assets owned by a person or entity. Total assets China Shineway Pharmaceutical Group Limited is 7 213 508 000 €
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
518 075 187.61 €
518 075 187.61 €
408 484 681.06 €
408 484 681.06 €
454 593 927.90 €
454 593 927.90 €
441 303 196.08 €
441 303 196.08 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
165 054 165.15 €
165 054 165.15 €
146 241 398.54 €
146 241 398.54 €
183 178 483.60 €
183 178 483.60 €
148 349 159.26 €
148 349 159.26 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
683 129 352.76 €
683 129 352.76 €
554 726 079.60 €
554 726 079.60 €
637 772 411.50 €
637 772 411.50 €
589 652 355.34 €
589 652 355.34 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
121 862 316.45 €
121 862 316.45 €
78 245 839.26 €
78 245 839.26 €
102 419 365.74 €
102 419 365.74 €
125 777 195.34 €
125 777 195.34 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
19 256 039.60 €
19 256 039.60 €
118 262 529.61 €
118 262 529.61 €
134 080 057.30 €
134 080 057.30 €
115 992 561.74 €
115 992 561.74 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
37 069 461.01 €
37 069 461.01 €
9 404 285.80 €
9 404 285.80 €
21 359 605.31 €
21 359 605.31 €
25 458 132.53 €
25 458 132.53 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
561 267 036.31 €
561 267 036.31 €
476 480 240.34 €
476 480 240.34 €
535 353 045.76 €
535 353 045.76 €
463 875 160 €
463 875 160 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
5 144 984 267.33 €
5 144 984 267.33 €
5 220 171 010.25 €
5 220 171 010.25 €
4 335 403 720.55 €
4 335 403 720.55 €
4 337 591 652.63 €
4 337 591 652.63 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
6 724 612 495.30 €
6 724 612 495.30 €
6 929 114 693.55 €
6 929 114 693.55 €
6 213 714 974.08 €
6 213 714 974.08 €
6 275 543 864.98 €
6 275 543 864.98 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
3 675 772 497.25 €
3 675 772 497.25 €
3 806 682 057.33 €
3 806 682 057.33 €
3 305 720 190.15 €
3 305 720 190.15 €
3 366 716 604.13 €
3 366 716 604.13 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
709 167 795.35 €
709 167 795.35 €
727 389 997.43 €
727 389 997.43 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
869 467 613 €
869 467 613 €
900 538 672.25 €
900 538 672.25 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
13.99 %
13.99 %
14.35 %
14.35 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
5 401 481 314.95 €
5 401 481 314.95 €
5 440 315 944 €
5 440 315 944 €
5 344 247 361.08 €
5 344 247 361.08 €
5 375 005 192.73 €
5 375 005 192.73 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
105 468 207.60 €
105 468 207.60 €
79 328 152.49 €
79 328 152.49 €
Last revenue report of China Shineway Pharmaceutical Group Limited was 31/12/2020. According to last financial report total revenue in China Shineway Pharmaceutical Group Limited was 683 129 352.76 Euro and changed by +15.85% since last year. Net income in China Shineway Pharmaceutical Group Limited was 19 256 039.60 € in last quartal, net income changes to -83.399%.
Current cash China Shineway Pharmaceutical Group Limited - the sum of all of the cash a company has on the date of report. Current cash China Shineway Pharmaceutical Group Limited is 3 943 010 000 €
China Shineway Pharmaceutical Group Limited stocks data
C1S.F stock price
China Shineway Pharmaceutical Group Limited stock price today, C1S.F stock quote.
